Showing results (1471-1480 of 1,769) with videos related to
Sort By:
Pageof 177
BMC Public Health|November 6, 2025
The Good School Toolkit-Secondary to prevent violence against students: a pilot cluster randomised controlled trialJodie Pearlman, Mathew Amollo, Clare Tanton, et al.In Silico Biology|December 4, 2012
Evaluation of viral heterogeneity using next-generation sequencing, end-point limiting-dilution and mass spectrometryZ Dimitrova, D S Campo, S Ramachandran, et al.ACS Applied Materials & Interfaces|February 11, 2020
Low-Resource Nucleic Acid Extraction Method Enabled by High-Gradient Magnetic SeparationStephanie I Pearlman, Mindy Leelawong, Kelly A Richardson, et al.Critical Care Research and Practice|June 11, 2019
Identification of Maltase Glucoamylase as a Biomarker of Acute Kidney Injury in Patients with CirrhosisLinda Awdishu, Shirley Tsunoda, Michelle Pearlman, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2015
Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ effluxMausita Karmakar, Michael Katsnelson, Hesham A Malak, et al.Plos One|March 23, 2023
Psychometric properties of the International Society of Wheelchair Professionals' basic manual wheelchair-service-provision knowledge Test Version 1 and development of Version 2Yohali Burrola-Mendez, R Lee Kirby, Paula W Rushton, et al.Journal of Medical Genetics|March 17, 2019
Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndromeRachel Pearlman, Sigurdis Haraldsdottir, Albert de la Chapelle, et al.Cancer Treatment Reports|April 1, 1983
Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancerN W Pearlman, T J Meyers, P E Siebert, et al.Translational Vision Science & Technology|December 19, 2024
Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular EdemaDavid S Boyer, Nathan C Steinle, Joel A Pearlman, et al.Contemporary Clinical Trials|October 8, 2022
Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial programBrian G Feagan, Stefan Schreiber, Anita Afzali, et al.Pageof 177